Scientists Have Discovered A New Method Of Detecting Cancer

Scientists Have Discovered A New Method Of Detecting Cancer.
A unknown assess marketed as an other to a mammogram for breast cancer detection is not an capable screening TOOL, US health officials say. With the nipple aspirate test, a heart pump collects unsettled from a woman's nipple. The fluid is then examined for queer and potentially cancerous cells pennis enlargement pills in kalmar. The test is advertised as easier, more undisturbed and less painful than mammograms.

However, there is no proof to support claims that the investigation can detect breast cancer, said Dr David Lerner, a medical bureaucrat at the US Food and Drug Administration and a core imaging specialist antiaging.herbalhat.com. "FDA's concern is that the nipple aspirate analysis is being touted as a standalone tool to screen for and name breast cancer as an alternative to mammography," Lerner said in an instrumentality news release.

So "Our fear is that women will forgo a mammogram and have this proof instead". Skipping a mammogram could put a woman's trim and life at risk if breast cancer goes undetected, Lerner warned. He said there is no orderly evidence that the nipple aspirate test, when utilized on its own, is an effective screening tool for bosom cancer or any other medical condition.

The test is still being studied to determine if it might be expedient in combination with other methods to screen for disease. "The bottom line is that women should not rely solely on these nipple aspirate tests for the screening or diagnosis of soul cancer. Mammography is still the gold standard".

In October, 2013, Atossa Genetics pulled its nipple aspirate probe - called the ForeCYTE Breast Health Test - off the merchandise after being warned by the FDA that its claims about the trial were unsubstantiated. The society claimed the evaluation was "literally a Pap anoint for breast cancer". Pap smears are a standard assay for cervical cancer.

And Women who have had a nipple aspirate test as a be composed of of breast cancer screening should also have a mammogram, according to screening guidelines or as recommended by their doctor. Also, they should patter to their doctor about whether additional tests are needed, the FDA said. One in eight US women will appear mamma cancer in her lifetime site. The disease is the back leading cancer killer of women in the country.